3.4 C
Glasgow
Sunday, November 30, 2025
spot_img

More News

Calcium-sensitive switch boosts cancer drugs’ efficacy

Jim Cornall -
Cancer-fighting antibody drugs are designed to penetrate tumour cells and release a lethal payload deep inside, but often they...

$120m investment to grow talent and innovation in Virginia

Jim Cornall -
A Memorandum of Understanding (MOU) signed by the Virginia Innovation Partnership Corporation (VIPC) and AstraZeneca, Eli Lilly (Lilly), and...

Potential of enzymatic single-stranded DNA for non-viral gene editing

Jim Cornall -
Moligo Technologies, a DNA synthesis company advancing gene therapies, has published an article in Nature Communications that demonstrates enzymatically...

The next era of CGT

Jim Cornall -
GenScript Biotech Corporation has hosted the GenScript Biotech Global Forum London 2025 in the UK. It is the forum's second...

FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Jim Cornall -
Pfizer Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV...

‘Groundbreaking’ rapid diagnostic test for prostate cancer

Jim Cornall -
A Welsh diagnostics company is developing a test it describes as ‘groundbreaking,’ which could detect prostate cancer in men...

Breakthrough in cancer immunotherapy using marine bacteria

Jim Cornall -
A research team led by Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute...

Trial results could shorten TB treatment time

Jim Cornall -
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the...

Customised cells to fight brain cancer

Jim Cornall -
With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain...

Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI

Jim Cornall -
This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the...

New technique could speed up design of drugs that target proteins

Jim Cornall -
An international team involving the Institute of Chemical Research, a joint centre of the University of Seville and the...

Fast track designation for diagnostic agent for clear cell renal cell carcinoma

Jim Cornall -
ITM Isotope Technologies Munich SE (ITM) has announced that the U.S. Food and Drug Administration (FDA) has granted Fast...

Sofinnova Partners closes $750m fund

Jim Cornall -
European life sciences venture capital company Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital...

‘Groundbreaking’ obesity drug data revealed

Jim Cornall -
CureGene Pharmaceuticals has announced what it calls ‘groundbreaking preclinical data’ for CG-0416, a novel oral non-GLP-1 weight-loss agent. It made...

SAS Clinical Acceleration debuts to modernise clinical trials and accelerate time to market

Jim Cornall -
Pharma and biotech companies face mounting pressure to accelerate drug development while maintaining rigorous compliance with global regulatory standards....

Cancer cells break through tight gaps in tissue

Jim Cornall -
When aggressive cancer cells spread through the body, they cause metastasis, which significantly reduces a person’s chance of survival....

Scottish Brain Sciences opens new Alzheimer’s clinical research centre

Jim Cornall -
Scottish Brain Sciences (SBS), a clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer's disease...

Genetic discovery links neurological disorders and psychiatric illnesses

Jim Cornall -
Researchers from the Centre for Precision Psychiatry at the University of Oslo and Oslo University Hospital have discovered extensive...

Trial could boost fight against neglected tropical diseases

Jim Cornall -
Millions of young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns...

New technique opens route to deep lung tumours

Jim Cornall -
Researchers at The University of Osaka in Japan have engineered a novel technique, balloon-assisted bronchoscope delivery (BDBD), to guide...

Breakthrough gives hope in fight against aggressive form of blood cancer

Jim Cornall -
Researchers at the University of Southampton in the UK have identified a new subtype of lymphoma which could pave...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media